Conjugate complexes for analyte detection

    公开(公告)号:EP2189539B2

    公开(公告)日:2018-06-13

    申请号:EP09175511.6

    申请日:2009-11-10

    IPC分类号: C12Q1/68

    摘要: The present invention relates to novel conjugate complexes for immunoassays as well as kits comprising these conjugate complexes, methods of producing these complexes, and methods of detecting an analyte by use of these complexes. The conjugate complexes of the invention comprise one or more non-nucleic acid receptors capable of specifically binding an analyte, one or more nucleic acid markers comprising a predetermined nucleotide sequence, one or more first linker molecules capable of specifically binding the non-nucleic acid receptor and the nucleic acid marker, and one or more second linker molecules capable of specifically binding the first linker molecules.

    MEANS AND METHODS FOR THE ENRICHMENT OF NUCLEIC ACIDS
    3.
    发明公开
    MEANS AND METHODS FOR THE ENRICHMENT OF NUCLEIC ACIDS 审中-公开
    MITTEL UND VERFAHREN ZUR ANREICHERUNG VONNUKLEINSÄUREN

    公开(公告)号:EP3154439A1

    公开(公告)日:2017-04-19

    申请号:EP16725089.3

    申请日:2016-05-19

    IPC分类号: A61B10/00 C12Q1/68

    摘要: The present invention relates to means for and methods of collecting, enriching, and analyzing nucleic acids of interest of interest, e.g. those that are associated with the development of sepsis. These means may be used in vivo or in vitro using obtained nucleic acids of interest, e.g. for liquid biopsies. The invention can, inter alia, be used in the detection and enrichment as well as analysis of nucleic acids of interests such as those derived from pathogens or from individuals that may contain such pathogens.

    摘要翻译: 本发明涉及收集,丰富和分析感兴趣的核酸的方法和方法,例如, 那些与败血症发展相关的那些。 这些方法可以在体内或体外使用获得的感兴趣的核酸,例如, 用于液体活检。 本发明特别可以用于检测和富集以及分析感兴趣的核酸,例如衍生自病原体的那些或可能含有这种病原体的个体。

    TARGETED DNA ENRICHMENT AND SEQUENCING
    4.
    发明公开
    TARGETED DNA ENRICHMENT AND SEQUENCING 有权
    靶向DNA富集和测序

    公开(公告)号:EP2844766A1

    公开(公告)日:2015-03-11

    申请号:EP13724179.0

    申请日:2013-04-29

    申请人: Qiagen GmbH

    IPC分类号: C12Q1/68

    摘要: The invention relates to a method for enriching one or more target sequences of a deoxyribonucleic acid (DNA) in a composition, comprising the steps of providing a composition comprising one or more deoxyribonucleic acid (DNA) molecules, hybridizing to said one or more DNA molecules, one or more target specific ribonucleic acid (RNA) hybridization probes, thereby forming one or more RNA/DNA hybrids, capturing the RNA/DNA hybrids with one or more antibodies being specific for such RNA/DNA hybrids, thereby forming one or more RNA/DNA/antibody hybrids, isolating the one or more RNA/DNA/antibody hybrids, amplifying the one or more DNA molecules of the one or more RNA/DNA/antibody hybrids if necessary, and, optionally, sequencing the one or more DNA molecules of the one or more RNA/DNA/antibody hybrids or the amplification product, wherein the sequencing is preferably done by means of next generation sequencing. The invention also relates to a kit comprising a first an antibody which is specific for a DNA/RNA hybrid molecule, wherein optionally the antibody is bound to a magnetic particle, and additionally comprising one or more target specific RNA hybridization probes.

    Conjugate complexes for analyte detection
    5.
    发明授权
    Conjugate complexes for analyte detection 有权
    分析物缀合复合物

    公开(公告)号:EP2189539B1

    公开(公告)日:2011-09-07

    申请号:EP09175511.6

    申请日:2009-11-10

    IPC分类号: C12Q1/68

    摘要: The present invention relates to novel conjugate complexes for immunoassays as well as kits comprising these conjugate complexes, methods of producing these complexes, and methods of detecting an analyte by use of these complexes. The conjugate complexes of the invention comprise one or more non-nucleic acid receptors capable of specifically binding an analyte, one or more nucleic acid markers comprising a predetermined nucleotide sequence, one or more first linker molecules capable of specifically binding the non-nucleic acid receptor and the nucleic acid marker, and one or more second linker molecules capable of specifically binding the first linker molecules.

    METHOD FOR IMMOBILIZING SUBSTANCES
    9.
    发明公开
    METHOD FOR IMMOBILIZING SUBSTANCES 审中-公开
    VERFAHREN ZUM IMMOBILISIENEN VON SUBSTANZEN

    公开(公告)号:EP1231470A1

    公开(公告)日:2002-08-14

    申请号:EP00971755.4

    申请日:2000-11-02

    IPC分类号: G01N33/543 G01N33/547

    摘要: A method for immobilizing substances by formation of plasma-polymerized films, after the arrangement of the substances to be immobilized on the surface of a support, and the immobilized substances according to the method are provided. The immobilized substances are retained with use of plasma-polymerized films, thereby damage to the immobilized substances is minimized, and the liberation of the substances after the immobilization will hardly occur. They can be further applied for indirect immobilization of biotinylated polynucleotides, because binding activities of the substances are kept on the surface. In addition, proteins having binding activities such as antibodies can be immobilized to be used for the detection of ligands.

    摘要翻译: 提供通过形成等离子体聚合膜来固定物质的方法,在待固定在载体表面上的物质的排列和根据该方法的固定化物质之后。 使用等离子体聚合膜保留固定化物质,使固定化物质的损伤减到最小,固定化后的物质的释放几乎不发生。 它们可以进一步应用于生物素化多核苷酸的间接固定,因为物质的结合活性保留在表面上。 此外,具有结合活性的蛋白质如抗体可以被固定以用于检测配体。

    METHOD AND SYSTEM FOR SEQUENCING IN CHARACTERIZATION OF ANTIBODY BINDING BEHAVIOR
    10.
    发明公开
    METHOD AND SYSTEM FOR SEQUENCING IN CHARACTERIZATION OF ANTIBODY BINDING BEHAVIOR 审中-公开
    测定抗体结合特性的方法和系统

    公开(公告)号:EP3307773A1

    公开(公告)日:2018-04-18

    申请号:EP16812371.9

    申请日:2016-06-15

    申请人: Ubiome, Inc.

    摘要: A method and system for characterization of antibody-bound targets by sequencing of synthetic oligonucleotides bound to the antibodies, the method including: receiving a sample having a set of antibodies; conjugating each of the set of antibodies with an oligonucleotide, thereby generating a set of oligonucleotide-conjugated antibodies; binding a first subset of the set of oligonucleotide-conjugated antibodies to a set of targets at a capture substrate; determining a sequence for at least one of: 1) each oligonucleotide of the first subset of oligonucleotide-conjugated antibodies that bind to the set of targets and 2) each oligonucleotide of a second subset of the set of oligonucleotide-conjugated antibodies that fail to bind to the set of targets; and generating an analysis of the sample from the sequences determined from at least one of the first and the second subsets of oligonucleotide-conjugated antibodies.